abstract |
The invention relates to medicine, in particular to the use of glycopyrrolate for the treatment of tachycardia, to a device for use, a method of treatment and prevention of tachycardia associated with other pathologies such as chronic obstructive bronchopneumopathy, bronchial asthma, cystic fibrosis and other diseases of the respiratory tract. According to the invention, the use of pharmaceutical an inhalation composition containing glycopyrrolate or a pharmaceutically acceptable salt thereof as a heart rate reducing agent |